Dayong Zhang

Dayong Zhang


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YWYue Wang
Yue Wang
RBRan Bi
Ran Bi
FQFei Quan
Fei Quan
QCQiuhua Cao
Qiuhua Cao
YLYanting Lin
Yanting Lin
DZDayong Zhang
Dayong Zhang

24 May 2017 in Organic Letters
Verified
Journal Article
Closed access
YLYi-Qian Li
Yi-Qian Li
QYQi-Liang Yang
Qi-Liang Yang
PFPing Fang
Ping Fang
TMTian-Sheng Mei
Tian-Sheng Mei
DZDayong Zhang
Dayong Zhang

6 February 2020 in Organic Letters
Verified
Journal Article
Closed access
YZYajing Zhang
Yajing Zhang
YSYouwen Sun
Youwen Sun
BCBin Chen
Bin Chen
MXMeichen Xu
Meichen Xu
CLChen Li
Chen Li
GZGuozhu Zhang
Guozhu Zhang

18 March 2020 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PDF file
JLJia-Qi Liu
Jia-Qi Liu
MZMing Zhao
Ming Zhao
ZZZhao Zhang
Zhao Zhang
LCLi-Yuan Cui
Li-Yuan Cui
XZXin Zhou
Xin Zhou
NCNaihong Chen
Naihong Chen

19 August 2022 in Science Advances
Verified
Journal Article
Open access
CCChengjuan Chen
Chengjuan Chen
YYYuan Yin
Yuan Yin
GSGaona Shi
Gaona Shi
YZYu Zhou
Yu Zhou
SSShuai Shao
Shuai Shao
TZTian-Tai Zhang
Tian-Tai Zhang
Janus kinases (JAKs) play a critical role in immune responses by relaying signals from more than 50 cytokines, making them attractive therapeutic targets for autoimmune diseases. Although approved JAK inhibitors have demonstrated clinical efficacy, they target a broad spectrum of cytokines, which results in side effects. Therefore, next-generation inhibitors maintain efficacy, while sparing adverse events need to be developed. Among members of the JAK family, JAK3 only regulates a narrow spectrum of γc cytokines and becomes a potentially ideal target. Here, a highly JAK3-selective inhibitor Z583 is developed, which showed a potent inhibition of JAK3 with an IC 50 of 0.1 nM and exhibited a 4500-fold selectivity for JAK3 than other JAK subtypes. Furthermore, Z583 completely inhibited the γc cytokine signaling and sufficiently blocked the development of inflammatory response in RA model, while sparing hematopoiesis. Collectively, the highly selective JAK3 inhibitor Z583 is a promising candidate with significant therapeutic potential for autoimmune diseases.

11 March 2015 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
LZLiangwei Zhang
Liangwei Zhang
XLXiangdong Li
Xiangdong Li
YLYuanhong Liu
Yuanhong Liu
DZDayong Zhang
Dayong Zhang
An efficient Pd-catalyzed cross-coupling/cycloisomerization of 3-(2-pyridyl) propargyl carbonates with organoboronic acids has been developed, which provides a straightforward route for the synthesis of 1,3-disubstituted indolizines with a wide variety of substituents. The mechanistic study indicates that the reaction proceeds via formation of an allenyl pyridine intermediate through palladium-catalyzed coupling reaction followed by cyclization.